KARA BOOTHBY: Open Payments
NPI 1356999189 · WASILLA, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,266 in 60 payments from 13 companies in 2025. Trend: 2023 $919 · 2024 $1,132 · 2025 $1,266
Food & beverage: $1,266
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $251 |
| GlaxoSmithKline, LLC. | 13 | $247 |
| ABBVIE INC. | 14 | $222 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $214 |
| Novo Nordisk Inc | 4 | $99 |
| Aimmune Therapeutics, Inc. | 2 | $60 |
| Digestive Care, Inc. | 1 | $39 |
| Electromed, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
| Exact Sciences Corporation | 1 | $23 |
Products named: CAPLYTA, TRELEGY ELLIPTA, VRAYLAR, AIRSUPRA, BREZTRI, UBRELVY, ZENPEP, Ozempic.
Industry payments across AK — which companies pay providers there.
